Advanced Code injection
0
Skip to Content
OBIO - Ontario Bioscience Innovation Organization
About OBIO
Governance
OBIO Team
Our Partners
Contact Us
At a Glance
Capital Access & Adoption
Skills Development & Training
Women in Health Initiative
Critical Technologies
Advocacy Efforts
All Events
OBIO Investment Summit
News & Press Releases
Tariff Relief Resources
Membership
Member Log in
Job Board
OBIO - Ontario Bioscience Innovation Organization
About OBIO
Governance
OBIO Team
Our Partners
Contact Us
At a Glance
Capital Access & Adoption
Skills Development & Training
Women in Health Initiative
Critical Technologies
Advocacy Efforts
All Events
OBIO Investment Summit
News & Press Releases
Tariff Relief Resources
Membership
Member Log in
Job Board
Folder: About
Back
About OBIO
Governance
OBIO Team
Our Partners
Contact Us
Folder: Areas of Focus
Back
At a Glance
Capital Access & Adoption
Skills Development & Training
Women in Health Initiative
Critical Technologies
Advocacy Efforts
Folder: Events
Back
All Events
OBIO Investment Summit
Folder: News
Back
News & Press Releases
Tariff Relief Resources
Folder: Membership
Back
Membership
Member Log in
Job Board
OBIO News, Ontario Industry Updates Arsheen Kaur 6/5/23 OBIO News, Ontario Industry Updates Arsheen Kaur 6/5/23

Able Innovations joins Mayo Clinic Innovation Exchange

Read More
Press Releases, OBIO News Doriane Rey 6/1/23 Press Releases, OBIO News Doriane Rey 6/1/23

New CHEO Research Institute study to examine feasibility and engagement with Mobio Interactive mobile mindfulness therapy for youth

Read More
OBIO News, Press Releases Doriane Rey 5/23/23 OBIO News, Press Releases Doriane Rey 5/23/23

Women’s College Hospital Evaluates Gotcare to Enhance Care Journey for Homebound Older Adults

Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 5/22/23 OBIO News, Ontario Industry Updates Arsheen Kaur 5/22/23

Pfizer Canada Launches National Initiative to Propel Startup Solutions for Key Challenges in Healthcare

Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 5/22/23 OBIO News, Ontario Industry Updates Arsheen Kaur 5/22/23

Satellos Bioscience Closes $55M Financing to Support Development of its Lead Drug Candidate for Duchenne Muscular Dystrophy

Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 5/22/23 OBIO News, Ontario Industry Updates Arsheen Kaur 5/22/23

CATTI opens a cell and gene therapy training centre of excellence at the University of Guelph

Read More
OBIO News Doriane Rey 5/18/23 OBIO News Doriane Rey 5/18/23

Insights from the "How I Raised" Event: Navigating Funding in HealthTech

Read More
OBIO News Doriane Rey 5/16/23 OBIO News Doriane Rey 5/16/23

Rendez-vous in the Capital: Networking with Inspirational Women in Science 

Read More
OBIO News, Press Releases Doriane Rey 5/16/23 OBIO News, Press Releases Doriane Rey 5/16/23

SCN and OBIO® partner to enhance the commercialization of life science innovations through specialized training for scientists

Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 5/9/23 OBIO News, Ontario Industry Updates Arsheen Kaur 5/9/23

Health Check Bus: Lung screening project in Taiwan reaches 8,000 mark

Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 5/9/23 OBIO News, Ontario Industry Updates Arsheen Kaur 5/9/23

Cyclica enters into agreement to be acquired by Recursion

Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 5/9/23 OBIO News, Ontario Industry Updates Arsheen Kaur 5/9/23

Able Innovations announced one of the winners at TiE Con 2023

Read More
OBIO News, Press Releases Doriane Rey 5/2/23 OBIO News, Press Releases Doriane Rey 5/2/23

Toch Sleepsense technology enables retirement home staff to monitor overnight bed-exits for seniors with real-time alerts

Read More
OBIO News, Ontario Industry Updates Doriane Rey 4/28/23 OBIO News, Ontario Industry Updates Doriane Rey 4/28/23

Ontario’s Life Sciences Council appoints experts including OBIO's CEO

Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 4/25/23 OBIO News, Ontario Industry Updates Arsheen Kaur 4/25/23

Enamine and Endogena Therapeutics – a successful, multi-year drug discovery collaboration

Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 4/25/23 OBIO News, Ontario Industry Updates Arsheen Kaur 4/25/23

Virica Biotech secures funding from Ontario government

Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 4/25/23 OBIO News, Ontario Industry Updates Arsheen Kaur 4/25/23

Over $16 million invested in Ontario's leading-edge genomics projects

Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 4/24/23 OBIO News, Ontario Industry Updates Arsheen Kaur 4/24/23

Aspect Biosystems & Novo Nordisk partner to develop bioprinted tissue therapeutics for diabetes and obesity

Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 4/24/23 OBIO News, Ontario Industry Updates Arsheen Kaur 4/24/23

MY01 raises CAD 12.5 million for microsensors to aid in physician diagnostics

Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 4/24/23 OBIO News, Ontario Industry Updates Arsheen Kaur 4/24/23

Zucara Therapeutics receives IND clearance for Phase 2 clinical trial of ZT-01

Read More
Newer Posts
Older Posts
Become an OBIO® Member Today!

Contact us:

OBIO®
101 College St., Suite HL50

Toronto, ON M5G 1L7

OBIO © 2025

(416) 848 6839
info@obio.ca

Media Kit

NEWSlETTER Sign UP

Terms & Conditions